About Careers MedBlog Contact us

Benefits and Risks of Intensive Glucose Treatment Must be Weighed Before Treating Patients

by Kathy Jones on July 1, 2010 at 11:04 PM
Font : A-A+

 Benefits and Risks of Intensive Glucose Treatment Must be Weighed Before Treating Patients

The benefits of intensive glucose therapy for diabetics need to be balanced against the increase in total and cardiovascular disease-related death, increased weight gain, and high risk for severe low blood sugar, scientists have said.

The study was aimed to determine whether intensive blood glucose (sugar) control worked better than standard blood sugar control among diabetics.


Dr. Faramarz Ismail-Beigi, a diabetes specialist with University Hospitals Case Medical Center, Case Western Reserve University, and colleagues conducted a study that examined patients who underwent intensive glucose-lowering treatment for 3.5 years.

The results did not see a reduced incidence of cardiovascular disease, or risk of progression in kidney failure, major vision loss, or advanced peripheral neuropathy, reports the Lancet.

There were some micro vascular improvements - reduced incidences of albuminuria in the intensive group, compared to those receiving standard treatment, along with fewer cataract extractions during the study period.

Visual acuity (sharpness of vision) and nerve function also improved for these patients.

Ismail-Beigi cautions that deciding the aggressiveness of therapy depends on what stage of the disease patients are in - for patients who are newly diagnosed with diabetes, intensive, aggressive therapy could delay the onset of some of the complications of diabetes, such as kidney disease and eye problems.

However, for those having diabetes for 10 years or more, intense therapy is associated with higher risk of cardiovascular death.

Source: ANI


Recommended Reading

Latest Diabetes News

How to Recognize the Signs of Unrecognized Cardiovascular Disease in Type 2 Diabetes?
In type 2 diabetes individuals, regular screening for two key cardiac biomarkers may decrease the risk of cardiovascular disease events.
 FDA Approves “Bionic Pancreas” For Type 1 Diabetes Management
The US Food and Drug Administration (FDA) clears the 'bionic pancreas' that improves the management of type 1 diabetes, without the need for constant blood sugar testing.
 1 In 5 “Healthy” People Actually Have Slightly Higher Blood Sugar Level
A new study investigated the use of a mathematical model of glucose metabolism to assess continuous glucose monitor data as a metric of dysfunctional glycemic control.
400 Medicinal Plants: Uncovering Their Anti-Diabetic Properties
At least 400 medicinal plants effective in decreasing sugar levels in the blood which is critical to control type 2 diabetes identified.
World's First Oral Insulin for Type-2 Diabetes
Considering the enormous type 2 diabetes patient population in China, a new oral insulin therapy will improve treatment.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Benefits and Risks of Intensive Glucose Treatment Must be Weighed Before Treating Patients Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests